---
schema_version: "secwatch.filing_event.v1"
accession: "0000096943-26-000031"
form_type: "8-K"
ticker: "TFX"
cik: "0000096943"
company_name: "TELEFLEX INC"
filed_at: "2026-03-17T23:59:59+00:00"
generated_at: "2026-05-15T11:18:23.840075+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Teleflex updates on OEM and Acute Care divestitures; FTC Second Request for urology deal

## Summary
- OEM HSR waiting period expired March 13, 2026; closing anticipated in Q3 2026.
- Acute Care and Urology deal received FTC Second Request on March 11, extending HSR review.
- Company and Intersurgical cooperating with FTC; close expected in H2 2026.
- Both transactions, announced Dec 9, 2025, are separate and subject to other conditions.

## SEC filing metadata
- accession: 0000096943-26-000031
- form_type: 8-K
- ticker: TFX
- cik: 0000096943
- company_name: TELEFLEX INC
- filed_at: 2026-03-17T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/96943/000009694326000031/0000096943-26-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/96943/000009694326000031/tfx-20260311.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000096943-26-000031
- JSON: https://secwatch.observer/filing/0000096943-26-000031.json
- Plain text: https://secwatch.observer/filing/0000096943-26-000031.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.